20065 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Synergistic enhancement of the delivery of nucleic acids via blended formulations
#1202Compositions and methods for delivering nucleic acid to a cell
#1203Cationic lipids for therapeutic agent delivery formulations
#1204Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery
#1205Formulations and carrier systems including compound interactive domains
#1206Dosages and methods for delivering lipid formulated nucleic acid molecules
#1207Modified polynucleotides for the production of nuclear proteins
#1208Hydrophobically modified antisense oligonucleotides comprising a triple alkyl chain
#1209Nanocarrier therapy for treating invasive tumors
#1210Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodies
#1211Compositions for delivery of drug combinations
#1212CELL PENETRATING PEPTIDE INTRODUCED DRUG-DELIVERY CARRIER COMPRISING MACROMOLECULE
#1213Methods and compositions for wound treatment
#1214CFTR mRNA compositions and related methods and uses
#1215Liposomes Useful for Drug Delivery
#1216Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
#1217USE OF LONG-ACTING HUMAN RECOMBINANT SOLUBLE TUMOR NECROSIS FACTOR A RECEPTOR IN THE PREPARATION OF DRUGS FOR PREVENTING AND TREATING SEVERE LIVER INJURY ON CHRONIC LIVER DISEASE
#1218Amino lipids and methods for the delivery of nucleic acids
#1219Liposomes useful for drug delivery
#1220Liposomes useful for drug delivery
#1221Liposomes Useful for Drug Delivery
#1222Modified polynucleotides for the production of biologics and proteins associated with human disease
#1223Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
#1224Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
#1225Methods and compositions for attenuating anti-viral transfer vector immune responses
#1226Anti-tumor compositions and methods
#1227COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR AND PULMONARY DISEASES AND DISORDERS WITH APELIN
#1228Compositions and methods for treating cancer
#1229Multistage delivery of active agents
#1230TARGETED LIPOSOMAL COMPOSITION USING ANTI-HER-2 AFFIBODY MOLECULES AND APPLICATIONS THEREOF IN CANCER TREATMENT
#1231Compositions and methods including celecoxib and plumbagin relating to treatment of cancer
#1232Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles
#1233Nanoparticle drug delivery systems
#1234Encapsulation of messenger RNA
#1235Methods and compositions for delivering mRNA coded antibodies
#1236IMMUNE-POTENTIATING DRUG NANOCARRIERS AND METHODS OF PRODUCTION AND USE THEREOF
#1237FKBP52 TARGETING AGENT PHARMACEUTICAL COMPOSITIONS
#1238Compositions and methods including leelamine and arachidonyl trifluoromethyl ketone relating to treatment of cancer
#1239PREPARATION AND CHARACTERIZATION OF BONE-TARGETED VANCOMYCIN-LOADED LIPOSOMES FOR OSTEOMYELITIS TREATMENT
#1240Liposomes useful for drug delivery
#1241Lipid-Coated Albumin Nanoparticle Compositions and Methods of Making and Method of Using the Same
#1242Nano / micro bubbles for drug delivery
#1243Pharmaceutical composition for preparing drug delivery nano/micro bubbles
#1244Controlled release nanoparticles and methods of use
#1245In vivo production of proteins
#1246Stereochemically enriched compositions for delivery of nucleic acids
#1247Process for formulating an anionic agent
#1248Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
#1249Modified polynucleotides for the production of secreted proteins
#1250Compositions and methods for treatment of cancer
#1251Lipids, lipid complexes and use thereof
#1252Hyaluronidase and a low density second PEG layer on the surface of therapeutic-encapsulated nanoparticles to enhance nanoparticle diffusion and circulation
#1253Mannose-receptor selective lysinylated cationic amphiphiles and a process for preparation thereof
#1254Synthetic platelets
#1255Viral immunogenic compositions
#1256Bufalin liposome, preparation method therefor and application thereof
#1257Encapsulated agents and methods of making and using thereof
#1258Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer
#1259PHARMACEUTICAL COMPOSITION CONTAINING CONVENTIONAL LIPOSOMES AND PROLONGED-CIRCULATION LIPOSOMES FOR THE TREATMENT OF VISCERAL LEISHMANIASIS
#1260Formulations and carrier systems including compound interactive domains
#1261Compositions and method for light triggered release of materials from nanovesicles
#1262Glycoconjugates and their use as potential vaccines against infection by
#1263TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS
#1264Induction of antigen-specific tolerance by peripheral phagocytosis
#1265DELIVERY COMPOSITIONS AND METHODS
#1266POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF
#1267SYSTEMS FOR TREATING PULMONARY INFECTIONS
#1268Recruitment of mensenchymal cells using controlled release systems
#1269Anti-cancer compositions and methods
#1270METHOD FOR COATING FINE PARTICLES WITH LIPID MEMBRANE
#1271CURCUMIN-ER, A LIPOSOMAL-PLGA SUSTAINED RELEASE NANOCURCUMIN FOR MINIMIZING QT PROLONGATION FOR CANCER THERAPY
#1272Liposomal lupeol acetate and the use thereof in preparing drugs for rheumatoid arthritis
#1273PREPARATION OF ANTIBODY OR AN ANTIBODY FRAGMENT TARGETED IMMUNOLIPOSOMES FOR SYSTEMIC ADMINISTRATION OF THERAPEUTIC OR DIAGNOSTIC AGENTS AND USES THEREOF
#1274Modified polynucleotides for the production of nuclear proteins
#1275LIPID COATED NANOPARTICLES CONTAINING AGENTS HAVING LOW AQUEOUS AND LIPID SOLUBILITIES AND METHODS THEREOF
#1276Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
#1277Boron cluster-modified PEG lipid derivative, and molecular assembly using same
#1278Amphoteric liposomes
#1279LEUKOCYTES AS DELIVERY CELLS FOR IMAGING AND DISEASE THERAPY
#1280Liposome formulations
#1281Nanoparticle formulation
#1282Liposome composition for use in peritoneal dialysis
#1283Liposomal compositions of epoxyketone-based proteasome inhibitors
#1284LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS
#1285Di-aliphatic substituted pegylated lipids
#1286Aminoalcohol lipidoids and uses thereof
#1287E2F as a target of hormone refractory prostate cancer
#1288LIPID MEMBRANE STRUCTURE HAVING INTRANUCLEAR MIGRATING PROPERTY
#1289LIPOSOMAL DRUG DELIVERY SYSTEM
#1290pH sensitive fluorescent polydiacetylene liposome and delivery vehicle comprising same
#1291ANTI-INTERLEUKIN-1 (IL-1) ANTIBODY USED AS A TARGETING AGENT TO TREAT ARTHRITIS AND OTHER DISEASES
#1292Vesicles comprising epidermal growth factor and compositions thereof
#1293Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
#1294Liposomes useful for drug delivery
#1295Modified polynucleotides for the production of cosmetic proteins and peptides
#1296Ionizable cationic lipids
#1297Lipid formulations for nucleic acid delivery
#1298Targeted liposomes in cancer therapy
#1299Tailored liposomes for the treatment of bacterial infections
#1300Ophthalmic drug delivery system containing phospholipid and cholesterol
#1301DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS
#1302CARRIER FOR INTRACELLULAR DELIVERY OF FUNCTIONAL PROTEIN
#1303CUSTOM-FORMULATED PHOSPHOLIPID MICROBUBBLES AND METHODS AND USES THEREOF
#1304Liposome and method for producing liposome
#1305Methods of treating inflammatory and autoimmune diseases and disorders using nanolipogels
#1306Nanoparticle, method of preparating the same, and use of the nanoparticle
#1307Lipid nanoparticle compositions and methods of making and methods of using the same
#1308Compositions and methods for silencing ebola virus gene expression
#1309In vivo production of proteins
#1310COMBINATION THERAPY FOR THE TREATMENT OF OVARIAN CANCER
#1311Liposome structures and methods of use thereof
#1312Lipid-derived neutral nanoparticles
#1313Liposome including complex of hydrophobic active ingredient and polypeptide and use of the liposome
#1314Lipid-based drug carriers for rapid penetration through mucus linings
#1315Sterically Stabilized Carrier For Aerosol Therapeutics, Compositions And Methods For Treating The Respiratory Tract Of A Mammal
#1316Composition for inactivating an enveloped virus
#1317Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
#1318Modified polynucleotides for the production of proteins
#1319Lipid-coated nucleic acid nanostructures of defined shape
#1320Liposomal corticosteroids for treatment of inflammatory disorders in humans
#1321Lipids and compositions for intracellular delivery of biologically active compounds
#1322Reversibly crosslinked micelle systems
#1323Nano delivery systems for siRNA
#1324Lipid construct for delivery of insulin to a mammal
#1325Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
#1326Coated devices and methods for coating
#1327Method and system for synthesizing nanocarrier based long acting drug delivery system for methadone
#1328Method and system for synthesizing nanocarrier based long acting drug delivery system for dexamethasone
#1329Method and system for synthesizing nanocarrier based long acting drug delivery system for buprenorphine
#1330Arginine-based lipids for delivery of therapeutics
#1331Method and system for synthesizing nanocarrier based long acting drug delivery system for morphine
#1332Biocompatible particles and method for preparing same
#1333Nanocell Drug Delivery System
#1334NOVEL LIPOSOME COMPOSITIONS
#1335Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
#1336Exosomes for delivery of biotherapeutics
#1337PATHOGEN AND SUBSTANCE TRAPS
#1338Liposomes and its production method
#1339Cationic lipid having improved intracellular kinetics
#1340Lipids, lipid complexes and use thereof
#1341Methods and compositions for X-ray induced release from pH sensitive liposomes
#1342Liposomes co-encapsulating a bisphosphonate and an amphipathic agent
#1343Alpha-aminoamidine polymers and uses thereof
#1344Compositions and methods relating to proliferative diseases
#1345Liposomal curcumin for treatment of diseases
#13463D expanding geometry
#1347Recombinant polypeptides for membrane fusion and uses thereof
#1348Lipids and lipid compositions for the delivery of active agents
#1349Pulmonary delivery of mRNA
#1350MRNA therapy for Fabry disease
#1351Lipid compositions for nucleic acid delivery
#1352Cationic lipids for therapeutic agent delivery formulations
#1353Temperature sensitive liposome including cationic lipid and use thereof
#1354Compositions for delivery of cargo such as drugs proteins and/or genetic materials
#1355Synthetic nanostructures including nucleic acids and/or other entities
#1356Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered In Vivo
#1357Cleavable lipids
#1358Acid stable liposomal compositions and methods for producing the same
#1359CELL BINDING PEPTIDE DRUG DELIVERY SYSTEM AND COMPOUND FOR TREATING CANCER AND TUMORS
#1360STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
#1361Modified polynucleotides for treating protein deficiency
#1362Intravenous Infusion of Curcumin and a Calcium Channel Blocker
#1363Vesicle compositions
#1364Components for producing amphoteric liposomes
#1365METHOD OF MONITORING THE RELEASE FROM LIPOSOMES OF A PRODUCT OF INTEREST USING SUPERPARAMAGNETIC NANOPARTICLES
#1366Modified polynucleotides for treating galactosylceramidase protein deficiency
#1367CERAMIDE ANIONIC LIPOSOME COMPOSITIONS
#1368HEMOGLOBIN-CONTAINING LIPOSOME AND METHOD FOR PRODUCING SAME
#1369Anti-cancer compositions and methods
#1370Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#1371Modified polynucleotides encoding basic helix-loop-helix family member E41
#1372Liposomes comprising polymer-conjugated lipids and related uses
#1373Compositions and methods for multimodal imaging
#1374Modified polynucleotides encoding citeD4
#1375Method for making nanolipidic particles
#1376Method for making nanolipidic particles
#1377Lipids and compositions for intracellular delivery of biologically active compounds
#1378Lipids and compositions for intracellular delivery of biologically active compounds
#1379Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
#1380Therapeutic muscular dystrophy drug having bubble liposome loaded with morpholino as active ingredient
#1381Use of umirolimus and its derivatives for treating cancer
#1382Liposomes useful for drug delivery
#1383Delivery substrates from aligned polymer biomaterials for tissue repair
#1384Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
#1385Stabilized nanobubbles for diagnostic and therapeutic applications
#1386Modified polynucleotides encoding septin-4
#1387Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
#1388Modified polynucleotides encoding granulysin
#1389Modified polynucleotides encoding apoptosis inducing factor 1
#1390Transpulmonary liposome for controlling drug arrival
#1391Modified polynucleotides encoding hepatitis A virus cellular receptor 2
#1392Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
#1393Modified polynucleotides encoding aquaporin-5
#1394Synthetic platelets
#1395SSH-2 (slingshot-2) inhibitors and methods for making and using them
#1396Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers
#1397Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
#1398Vector for pulmonary delivery, inducing agent, and uses
#1399Nanolipidic particle assembly populations
#1400COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL
#1401Nanoparticles delivery systems, preparation and uses thereof
#1402Liposome composition
#1403Liposomal apparatus and manufacturing methods
#1404Amino acid lipids and uses thereof
#1405Cyclic peptide and conjugate thereof for binding to keratinocytes
#1406Delivery of nucleic acid-like compounds
#1407BIOPOLYMER HOOKS TO CREATE COATINGS ON LIPOSOMES
#1408MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#1409Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
#1410Sustained-release liposomal anesthetic compositions
#1411Systems for treating pulmonary infections
#1412Compositions and methods for making and using multifunctional polymerized liposomes
#1413Lipid nanoparticle compositions for antisense oligonucleotides delivery
#1414Lipid-polymer hybrid particles
#1415Blood substitutes and uses thereof
#1416Carrier-linked magnetic nanoparticle drug delivery composition and method of use
#1417Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
#1418Lipid construct for delivery of insulin to a mammal
#1419LIPID CARRIER FOR DELIVERY OF BIOACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION
#1420GENERATION OF VIROSOME PARTICLES
#1421Modified polynucleotides for the production of biologics and proteins associated with human disease
#1422Modified polynucleotides for the production of secreted proteins
#1423Formulation and delivery of PLGA microspheres
#1424Formulation and delivery of PLGA microspheres
#1425Split dose administration
#1426Method for preparing liposome-based constructs
#1427TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS
#1428Anti-C-met antibody and methods of use thereof
#1429Particles of tetracyclines and protecting agent
#1430Small liposomes for delivery of immunogen encoding RNA
#1431Liver specific delivery of messenger RNA
#1432Nanostructure suitable for sequestering cholesterol and other molecules
#1433Sustained-release liposomal anesthetic compositions
#1434Nano-scale contrast agents and methods of use
#1435Graft copolymer polyelectrolyte complexes for drug delivery
#1436Method for formulating large diameter synthetic membrane vesicles
#1437Method for formulating large diameter synthetic membrane vesicles
#1438Method for formulating large diameter synthetic membrane vesicles
#1439Liposomes for the treatment of textile materials
#1440Method for formulating large diameter synthetic membrane vesicles
#1441Method for formulating large diameter synthetic membrane vesicles
#1442Method for formulating large diameter synthetic membrane vesicles
#1443Octreotide-modified nanomedicine for cancer treatment or cancer palliative care
#1444Single use system for sterilely producing lipid-nucleic acid particles
#1445Formulation of PEGylated-liposome encapsulated glycopeptide antibiotics
#1446Telodendrimer nanodiscs without apolipoprotein
#1447Liposome targeting compounds and related uses
#1448MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS
#1449Asymmetric liposomes for the highly efficient encapsulation of nucleic acids and hydrophilic anionic compounds, and method for preparing same
#1450Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
#1451Prodrug compositions, prodrug nanoparticles, and methods of use thereof
#1452Liposomes useful for drug delivery
#1453Method of producing lipid nanoparticles for drug delivery
#1454Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseases
#1455Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseases
#1456Compositions and methods for treating influenza
#1457Soluble tumor necrosis factor receptor (sTNF-R) used as a targeting agent to treat arthritis and other diseases
#1458Localization of agents at a target site with a composition and an energy source
#1459THERANOSTIC DELIVERY SYSTEMS WITH MODIFIED SURFACES
#1460UNIVERSAL CELL-DIRECTED THERANOSTICS
#1461LIPOSOMES COMPRISING AMPHIPATHIC DRUGS AND METHOD FOR THEIR PREPARATION
#1462Methods of Treatment Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production
#1463STEROID HORMONE DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME
#1464INTRANASAL LOWER DOSAGE STRENGTH TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
#1465Viral Immunogenic Compositions
#1466Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
#1467Preparation of Lipid Nanoparticles
#1468SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES
#1469Therapeutic agent for pulmonary fibrosis
#1470Forming an Artificial Cell with controlled membrane composition, asymmetry, and contents
#1471Triggered Cargo Release from Nanoparticle Stabilized Liposomes
#1472Polymer-liposome nanocomposite composition for percutaneous absorption, and method for preparing same
#1473METHODS AND COMPOSITIONS FOR TRANSFER OF MITOCHONDRIA INTO MAMMALIAN CELLS
#1474Cationic lipids for therapeutic agent delivery formulations
#1475SNALP FORMULATIONS CONTAINING ANTIOXIDANTS
#1476Compounds for targeting drug delivery and enhancing siRNA activity
#1477Human respiratory syncytial virus vaccine
#1478Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
#1479POTENT D-PEPTIDE ANTAGONISTS OF MDM2 AND MDMX FOR ANTICANCER THERAPY
#1480Methods of using dual-effect liposome in therapy
#1481FRAMELESS INTRAUTERINE DEVICES AND SYSTEMS
#1482Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
#1483Micelle composition of polymer and passenger drug
#1484Lipids and compositions for intracellular delivery of biologically active compounds
#1485Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
#1486METHOD FOR ADMINISTRATION OF PEGYLATED LIPOSOMAL DOXORUBICIN
#1487ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING LOW CONCENTRATIONS OF PHOSPHATIDYLETHANOLAMINE
#1488Ceramide anionic liposome compositions
#1489MUC1 based glycolipopeptide vaccine with adjuvant
#1490LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF
#1491THERAPEUTIC AGENT FOR PULMONARY FIBROSIS
#1492Vaccine for Modulating Between T1 and T2 Immune Responses
#1493Vaccine for modulating between T1 and T2 immune responses
#1494COMPOSITIONS AND METHODS FOR ENHANCING CELLULAR UPTAKE AND INTRACELLULAR DELIVERY OF LIPID PARTICLES
#1495Self-assembled particles from zwitterionic polymers and related methods
#1496COMPOSITIONS AND METHODS FOR DELIVERING RNAI USING APOE
#1497COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE
#1498ENDOPLASMIC RETICULUM TARGETING LIPOSOMES
#1499Sustained-release liposomal anesthetic compositions
#1500Vesicle compositions